PIK3CB and prostate cancer: Furthermore, FK-A11, an analog of depsipeptide, is reported to be the most potent HDAC/PI3K dual inhibitor exhibiting antitumor activity in HT1080 fibrosarcoma and PC3 prostate cancer cell xenograft mouse models [149].